Related references
Note: Only part of the references are listed.Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Encenicline, a Selective alpha(7) Nicotinic Receptor Partial Agonist, in Single Ascending-dose and Bioavailability Studies
Ann J. Barbier et al.
CLINICAL THERAPEUTICS (2015)
Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale
Richard S. E. Keefe et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition: A Proof of Concept, Randomized Trial in Patients with Schizophrenia
Sheldon H. Preskorn et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2014)
The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens
Mei Huang et al.
PSYCHOPHARMACOLOGY (2014)
EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors
Jos Prickaerts et al.
NEUROPHARMACOLOGY (2012)
Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial
Richard S. E. Keefe et al.
SCHIZOPHRENIA RESEARCH (2011)
Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex
Paul Maruff et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2009)
Relationship of cognition and psychopathology to functional impairment in schizophrenia
Somaia Mohamed et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
The MATRICS consensus cognitive battery, part 2: Co-norming and standardization
Robert S. Kern et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
The MATRICS consensus cognitive battery, part 1: Test selection, reliability, and validity
Keith H. Nuechterlein et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants
Kelly Posner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
SSR180711, a novel selective alpha 7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia
Philippe Pichat et al.
NEUROPSYCHOPHARMACOLOGY (2007)
The schizophrenia cognition rating scale: An interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity
RSE Keefe et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria
MF Green et al.
BIOLOGICAL PSYCHIATRY (2004)
The heterogeneity of schizophrenia in disease states
PE Mohr et al.
SCHIZOPHRENIA RESEARCH (2004)
Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates
RM Bilder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Share Paper
